Comprehensive tissue management system

• US 20080077432A1
• Filed: 09/29/2006
• Published: 03/27/2008
• Est. Priority Date: 09/21/2006
• Status: Abandoned Application

• Current Assignee: Biomedical Synergies, Inc.
• Original Assignee: Biomedical Synergies, Inc.
• Inventors: Kasprisin, Duke O.
• Application Number:
  US11/540,844
• Publication Number:
  US 20080077432A1
• Time in Patent Office: Days
• US Class Current: 705/2
• CPC Class Codes: G06Q 10/00 Administration; Management
• CPC Class Codes: G16H 10/40 for data related to laboratory analysis, e.g. patient specimen analysis
• CPC Class Codes: G16H 40/20 for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms

Abstract

The present invention provides a comprehensive tissue management method and system for transplantable materials like tissues and organs. The tracking portion of the system verifies that staff members of a medical establishment like a hospital have handled, stored, transported, reconstituted, and used the tissue or organ materials in a safe and regulatory-compliant manner from the point of receipt to the point of issuance or surgical use throughout the hospital'"'"'s organization. The tracing portion of the system creates an integral record that documents which hospital staff members have provided which processing steps to the tissue or organ, any associated materials used in conjunction with such tissue or organ, and an identification of the tissue or organ that was transplanted or implanted inside a patient. Such a system will enable adverse reaction investigations for transplant patients.

Claims

1. A method for tracking the internal processing by a medical establishment of a piece of transplantable material provided by a supplier for subsequent transplantation or implantation into a patient, such method comprising:

(a) assigning a unique identification code to the transplantable material upon its receipt by the medical establishment from the supplier;

(b) inspecting the transplantable material upon its receipt from the supplier for an unsafe condition.

(c) ensuring that each processing step comprising handling, storage, reconstitution or surgical use of the transplantable material by staff members of the medical establishment is conducted strictly in a manner compliant with prevailing regulations and industry standards;

(d) assessing the patient after transplantation or implantation of the transplantable material for evidence of an adverse effect;

(e) investigating any such adverse effect discovered in the patient to determine whether it constitutes an adverse reaction; and

(f) reporting any such adverse reaction to the supplier that supplied the transplant material to the medical establishment.

2. The transplantable material tracking method of claim 1 further comprising designating one or more staff members of the medical establishment with specific responsibility for conducting each of the steps (a-f).

3. The transplantable material tracking method of claim 1 further comprising the step of certifying that the supplier currently possesses all required regulatory certifications and licenses to supply the transplantable material

4. The transplantable material tracking method of claim 1 further comprising evaluating the safety or health risks posed by transplantable materials supplied by the supplier against the benefits provided by such transplantable materials.

5. The transplantable material tracking method of claim 4, wherein input from a transplant surgeon is obtained when conducting the risk-benefit analysis.

6. The transplantable material tracking method of claim 1 further comprising ensuring that a staff member of the medical establishment who performs any of the steps (a-f) possesses a relevant educational background for performing such step.

7. The transplantable material tracking method of claim 1 further comprising providing relevant training to a staff member of the medical establishment who performs any of the steps (a-f).

8. The transplantable material tracking method of claim 1 further comprising providing relevant policies or procedures in support of the reliable conduct of any of the steps (a-f).

9. The transplantable material tracking method of claim 1 further comprising periodic auditing of the medical establishment to ensure that each step (a-f) is being conducted properly.

10. The method for tracing a piece of transplantable material received by a medical establishment from a supplier throughout the internal life of the transplantable material within the medical establishment until it is transplanted or implanted into a patient, such method comprising:

(a) assigning a unique identification code for the transplantable material upon its receipt by the medical establishment from the supplier;

(b) documenting each processing step comprising login, handling, storage, reconstitution, or surgical use applied by staff members to the transplantable material;

(c) documenting the identity of each staff member who comes into contact with the transplantable material;

(d) documenting the date and time of each processing step applied to the transplantable material;

(e) documenting all materials used to prepare and process the transplantable material;

(f) documenting the unique identification code of the transplantable material transplanted or implanted into the patient; and

(g) tracing the transplantable material back to the supplier that supplied it to the medical establishment or to the specific processing step applied by a staff member of the medical establishment to the transplantable.

11. The transplantable material tracing method of claim 10 further comprising designating one or more staff members of the medical establishment with specific responsibility for conducting each of the steps (a-g).

12. The transplantable material tracing method of claim 10 further comprising sending to the supplier a tissue utilization information card for the transplantable material transplanted or implanted to the patient.

13. The transplantable material tracing method of claim 10, wherein the tracing step is conducted in response to an adverse reaction detected in the patient into whom the transplantable material was transplanted or implanted.

14. The transplantable material tracing method of claim 13, wherein the supplier that supplied the transplantable material to the medical establishment is notified of the adverse reaction in the patient.

15. The transplantable material tracing system of claim 10, wherein the tracing step is conducted in response to a warning received from the supplier that supplied the transplantable material to the medical establishment.

16. The transplantable material tracing system of claim 13, wherein the adverse reaction investigations is conducted utilizing medical cladistics to identify risk clades.

17. The transplantable material tracing method of claim 10 further comprising ensuring that a staff member of the medical establishment who performs any of the steps (a-g) possesses a relevant educational background for performing such step.

18. The transplantable material tracing method of claim 10 further comprising providing relevant training to a staff member of the medical establishment who performs any of the steps (a-g).

19. The transplantable material tracing method of claim 10 further comprising providing relevant policies or procedures in support of the reliable conduct of any of the steps (a-g).

20. The transplantable material tracing method of claim 10 further comprising periodic auditing of the medical establishment to ensure that each step (a-g) is being conducted properly.